Skip to main content
. Author manuscript; available in PMC: 2011 Aug 1.
Published in final edited form as: J Thorac Oncol. 2010 Aug;5(8):1279–1284. doi: 10.1097/JTO.0b013e3181e2fcb0

Table 4.

Efficacy

All Pts
(N)		 45 mg QD
(N)		 30 mg QD
(N)
Objective Response 1* 0 1*
Stable disease 9 5 4
Progression 14 6 8
N/A 1 1 0
Median PFS 2 m 2 m 2 m
Median Survival 6 m 6 m m
*

unconfirmed response